港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

生物醫藥B類股

618.706

+13.1722.18%

漲家數：23

跌家數：8

平家數：3

市盈率：- -

高：627.633

開：605.584

低：600.085

收：605.533

成交量：1.29億

成交額：38.26億

市值：3,831.01億

流通市值：3,410.50億

資料載入中...

復宏漢霖CEO朱儁：創新藥出海忌迷信經驗、「倚老賣老」｜36氪專訪

心瑋醫療-B10月31日主力淨流入21.2萬元散户資金拋售

歌禮制藥-B10月31日獲主力加倉577.7萬元

沛嘉醫療-B10月31日主力淨流入59.5萬元散户資金拋售

邁博藥業-B10月31日主力淨流出25.4萬元散户資金買入

藥明巨諾-B10月31日主力淨流入68.8萬元散户資金拋售

亞盛醫藥-B10月31日獲主力加倉402.8萬元

先瑞達醫療-B10月31日主力淨流出69.8萬元散户資金買入

賽諾醫療(688108.SH)：棘突球囊產品獲得國外醫療器械註冊證

雙利好共振！槓桿資金搶籌績優醫藥股(附表)

东方财富研究中心

基金經理毛可君：創新藥調整或不改產業趨勢

戴維醫療(300314.SZ)：「電子內窺鏡圖像處理器」醫療器械註冊獲得受理

暴跌23%後又大漲近5%！創新藥佈局機遇來了？業內大咖最新研判

中国基金报

機會速遞 | 中信證券：港股風偏或上行；創新藥三季度業績亮眼，與醫保談判啓動共振，這些細分行業受關注

啱啱 20%漲停！重磅消息引爆！

身價超越宗馥莉，中國新晉女首富什麼來頭？

創新藥，又現集體大漲

康諾亞-B盤中異動股價大漲5.06%

醫保談判啓動，首次正式引入商保創新藥目錄機制！恒生創新藥ETF(520500)交投活躍昨日成交額環比大增約300%

算力突發「易中天」大跌！行業迎利好熱門概念股「20cm」漲停孖展客看好這些績優股

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1574/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":618.7055,"timestamp":1761898110601,"preClose":605.53326,"halted":0,"volume":128593457,"delay":0,"changeRate":0.021753,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":13.172241,"latestTime":"10-31 16:00:00","open":605.58374,"high":627.6333,"low":600.08484,"amount":3826218301,"amplitude":0.045495,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1762133400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1761874200000,1761883200000],[1761886800000,1761897600000]],"pbRate":5.343409,"peRate":-44.036334,"turnoverRate":0.004666,"increases":23,"decrements":9,"flats":1,"marketCap":383100705664,"floatMarketCap":341050329040},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":627.6333,"amplitude":0.045495,"preClose":605.53326,"low":600.08484,"pbRate":"5.343409","latestPrice":618.7055,"volume":128593457,"delay":0,"open":605.58374,"prevYearClose":331.1933,"prevWeekClose":617.318,"prevMonthClose":618.706,"prevQuarterClose":752.859,"fiveDayClose":615.593,"twentyDayClose":752.859,"sixtyDayClose":779.344,"secType":"PLATE","market":"HK","turnoverRate":0.004666,"peRate":-44.036334,"marketCap":383100705664,"floatMarketCap":341050329040,"timestamp":1761898110601,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":23,"down":8,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579960824","title":"復宏漢霖CEO朱儁：創新藥出海忌迷信經驗、「倚老賣老」｜36氪專訪","url":"https://stock-news.laohu8.com/highlight/detail?id=2579960824","media":"36氪","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579960824?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:22","pubTimestamp":1761898931,"startTime":"0","endTime":"0","summary":"今年上半年，复宏汉霖的总营收为28亿元、净利润3.9亿元。在谈及推动新药出海方面的经验时，他犀利指出，做创新药忌讳“倚老卖老”，最大的经验是“不要被经验限制”。谈及在推动新药出海方面的经验时，朱俊认为，做创新药忌讳“倚老卖老”，尤其是在和全球不同的监管部门沟通时，经验有时反倒会成为“包袱”。据了解，复宏汉霖在这项研究上的投入已接近2亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162512a6d875ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162512a6d875ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02696","06978","BK1574","BK1161"],"gpt_icon":0},{"id":"2580440794","title":"心瑋醫療-B10月31日主力淨流入21.2萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2580440794","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580440794?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898559,"startTime":"0","endTime":"0","summary":"10月31日, 心玮医疗-B股价涨1.77%，报收54.50元，成交金额59.7万元，换手率0.04%，振幅2.89%，量比0.32。心玮医疗-B今日主力资金净流入21.2万元，上一交易日主力净流出47.3万元。该股近5个交易日下跌0.27%，主力资金累计净流入15.9万元；近20日主力资金累计净流出46.0万元，其中净流出天数为4日。该股主力净额占比0.01%，港股市场排名295/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116233194e71aa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116233194e71aa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06609","BK1100","BK1587","BK1574"],"gpt_icon":0},{"id":"2580416731","title":"歌禮制藥-B10月31日獲主力加倉577.7萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416731","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416731?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898557,"startTime":"0","endTime":"0","summary":"10月31日, 歌礼制药-B股价涨3.65%，报收9.65元，成交金额3623.7万元，换手率0.38%，振幅6.55%，量比1.34。歌礼制药-B今日主力资金净流入577.7万元，上一交易日主力净流入33.4万元。该股近5个交易日上涨6.33%，主力资金累计净流入479.8万元；近20日主力资金累计净流出751.2万元，其中净流出天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116232394e71a93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116232394e71a93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01672","01477","BK1161","BK1515","BK1574"],"gpt_icon":0},{"id":"2580131484","title":"沛嘉醫療-B10月31日主力淨流入59.5萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2580131484","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580131484?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898545,"startTime":"0","endTime":"0","summary":"10月31日, 沛嘉医疗-B股价涨5.08%，报收6.00元，成交金额937.1万元，换手率0.23%，振幅6.65%，量比1.70。沛嘉医疗-B今日主力资金净流入59.5万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.17%，主力资金累计净流入59.5万元；近20日主力资金累计净流出407.6万元，其中净流出天数为7日。该股主力净额占比0.01%，港股市场排名276/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162056974bebf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031162056974bebf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","BK1574","09996"],"gpt_icon":0},{"id":"2580428264","title":"邁博藥業-B10月31日主力淨流出25.4萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2580428264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580428264?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898537,"startTime":"0","endTime":"0","summary":"10月31日, 迈博药业-B股价跌8.77%，报收0.52元，成交金额87.9万元，换手率0.04%，振幅7.02%，量比5.15。迈博药业-B今日主力资金净流出25.4万元，上一交易日主力净流出0万元。该股近5个交易日下跌13.33%，主力资金累计净流出25.4万元；近20日主力资金累计净流出86.9万元，其中净流出天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161933a6d871c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161933a6d871c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02181","BK1161"],"gpt_icon":0},{"id":"2579458712","title":"藥明巨諾-B10月31日主力淨流入68.8萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2579458712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579458712?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898536,"startTime":"0","endTime":"0","summary":"10月31日, 药明巨诺-B股价涨0.87%，报收3.48元，成交金额1069.6万元，换手率0.75%，振幅5.80%，量比1.30。药明巨诺-B今日主力资金净流入68.8万元，上一交易日主力净流出165.5万元。该股近5个交易日下跌0.85%，主力资金累计净流出72.8万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出768.3万元，其中净流出天数为8日。该股主力净额占比0.05%，港股市场排名153/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161940974beb3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161940974beb3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02126","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2580486584","title":"亞盛醫藥-B10月31日獲主力加倉402.8萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580486584","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580486584?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898530,"startTime":"0","endTime":"0","summary":"10月31日, 亚盛医药-B股价涨2.31%，报收66.50元，成交金额2.2亿元，换手率0.89%，振幅5.62%，量比1.39。亚盛医药-B今日主力资金净流入402.8万元，上一交易日主力净流入145.5万元。该股近5个交易日上涨0.46%，主力资金累计净流入182.3万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出1320.2万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161833974beaa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161833974beaa1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","06855"],"gpt_icon":0},{"id":"2579519844","title":"先瑞達醫療-B10月31日主力淨流出69.8萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2579519844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579519844?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:15","pubTimestamp":1761898530,"startTime":"0","endTime":"0","summary":"10月31日, 先瑞达医疗-B股价跌1.31%，报收12.10元，成交金额934.9万元，换手率0.25%，振幅5.95%，量比1.61。先瑞达医疗-B今日主力资金净流出69.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.89%，主力资金累计净流出69.8万元；近20日主力资金累计净流入194.4万元，其中净流入天数为6日。该股主力净额占比0.02%，港股市场排名2422/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161819974bea7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031161819974bea7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1100","06669","BK1587"],"gpt_icon":0},{"id":"2579458463","title":"賽諾醫療(688108.SH)：棘突球囊產品獲得國外醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2579458463","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579458463?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:12","pubTimestamp":1761898374,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛诺医疗(688108.SH)发布公告，近日，公司TRADENT TM冠状动脉棘突球囊扩张导管获得韩国食品医药品安全部(简称MFDS)的批准，在韩国获得《医疗器械注册证》。该产品是一种球囊嵌入在棘突丝内的导管，适用于扩张冠状动脉狭窄。公司TRADENT TM冠状动脉棘突球囊扩张导管在韩国获得注册证，有效增加了公司海外业务的在售产品品类。该产品在韩国上市后，将与公司冠脉支架、冠脉球囊等产品形成有效的产品组合，进一步利用公司的海外渠道资源，将对公司产品在海外的销售起到一定的推动和促进作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1222","BK1100","BK0251","BK1574","09996","09997","BK1583","688108"],"gpt_icon":0},{"id":"2579455897","title":"雙利好共振！槓桿資金搶籌績優醫藥股(附表)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579455897","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579455897?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:10","pubTimestamp":1761898208,"startTime":"0","endTime":"0","summary":"越跌越买杠杆资金抢筹绩优股东方财富Choice数据显示，自9月2日医药生物板块调整以来，杠杆资金抢筹多只三季报净利润增长率超20%以上的个股。内外双利好共振消息面上，10月30日，2025年国家医保谈判在北京开启。今年国谈在延续医保目录常规调整机制的基础上，首次正式引入“商保创新药目录”机制。根据国家医保局8月28日公告，2025年基本药品目录调整有535个药品通用名通过形式审查。而10月份以来国产创新药“出海”进程明显提速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116262294e71bf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116262294e71bf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","LU0708995583.HKD","BK1574","LU2045819591.USD","LU2125910500.SGD","LU2242644610.SGD","BK1576","BK1161","LU0052750758.USD","02359","09995","BK1583","LU1046422090.SGD","09939","BK1141","BK1515"],"gpt_icon":0},{"id":"2579453827","title":"基金經理毛可君：創新藥調整或不改產業趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2579453827","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579453827?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 16:00","pubTimestamp":1761897600,"startTime":"0","endTime":"0","summary":"基金经理毛可君认为，创新药调整或不改产业趋势。尽管创新药受短期情绪冲击较大，中国创新药产业趋势的向上力量值得持续重点关注。所以本轮创新药表面上似乎是由BD交易而驱动，但本质上是由产业趋势驱动的。基金管理人不保证基金一定盈利，也不保证最低收益。基金管理人不对基金投资收益做出任何承诺或保证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116061994e71335&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116061994e71335&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","03759","LU2097828557.USD","LU2328871848.SGD","06160","LU2097828474.EUR","BK1589","06978","BK1161","LU0455707207.USD","LU2097828714.EUR","LU1969619763.USD","09995","01801","LU2097828631.EUR","LU2242644610.SGD","LU0502904849.HKD","BK1583","02359","LU2097828805.USD","BK1574","01093"],"gpt_icon":1},{"id":"2579430255","title":"戴維醫療(300314.SZ)：「電子內窺鏡圖像處理器」醫療器械註冊獲得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2579430255","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579430255?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 15:55","pubTimestamp":1761897326,"startTime":"0","endTime":"0","summary":"智通财经APP讯，戴维医疗 发布公告，公司全资子公司宁波维尔凯迪医疗器械有限公司于近日取得由浙江省药品监督管理局颁发的1项《受理通知书》，该产品为：“电子内窥镜图像处理器”。维尔凯迪开发的电子内窥镜图像处理器配套开发的电子内窥镜产品使用。电子内窥镜图像处理器可适配泌尿、消化、呼吸等多领域电子内窥镜微创诊疗场景，满足不同解剖部位的检查与治疗操作需求，完善公司在微创医疗领域的产品布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09996","BK1100","BK1583","BK1574","BK0251","BK1222","300314","BK0048","09997","BK0046","159883","BK0042"],"gpt_icon":0},{"id":"2579227437","title":"暴跌23%後又大漲近5%！創新藥佈局機遇來了？業內大咖最新研判","url":"https://stock-news.laohu8.com/highlight/detail?id=2579227437","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579227437?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 15:27","pubTimestamp":1761895669,"startTime":"0","endTime":"0","summary":"自2025年1月1日至9月上旬，恒生创新药指数最大涨幅达141.24%。不过，从9月上旬至10月30日收盘，该指数持续调整近两个月。其间，最大跌幅达22.63%。然而，10月31日，恒生创新药指数大涨，最高涨幅达4.84%；截至记者发稿，涨幅为4.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1345,202510313551874972.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1345,202510313551874972.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["159992","BK1574","06978","BK1161"],"gpt_icon":0},{"id":"2579430275","title":"機會速遞 | 中信證券：港股風偏或上行；創新藥三季度業績亮眼，與醫保談判啓動共振，這些細分行業受關注","url":"https://stock-news.laohu8.com/highlight/detail?id=2579430275","media":"哈富证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579430275?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 15:12","pubTimestamp":1761894735,"startTime":"0","endTime":"0","summary":"板块聚焦：创新药概念逆市走高，2025年国家医保谈判启动，多家药企三季度业绩亮眼消息面上，10月30日，2025年国家医保谈判在北京开启。该机构认为港股市场风偏或上行，建议关注原材料、对美出口板块，以及或受益于人民币升值的航空与造纸等板块。公告称，康希诺第三季度业绩的强劲增长，主要源于核心产品曼海欣的市场表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031154035a6d85dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031154035a6d85dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1770036033.HKD","LU0593848301.USD","01772","BK1161","LU0871576103.HKD","BK1574","06978","SG9999001069.SGD","03750","01801","LU1481107354.HKD","LU0211977185.USD","LU0149721374.USD","SG9999002950.SGD","LU0345776255.USD","LU1720050803.USD","09606","06030","LU0039217434.USD","LU0164880469.USD","LU0823426308.USD","LU0572944931.SGD","LU0531971595.HKD","LU0164865239.USD","LU0348767384.USD","LU0611395673.USD","02517","LU1023057109.AUD","06166","SGXZ86797644.SGD","BK1564","LU0499858602.USD","LU0327786744.USD","LU1794554557.SGD","09696","BK1224","BK1516","LU0307460666.USD","LU0588546209.SGD","LU0345775950.USD","LU0359202008.SGD","LU0359201612.USD","09992","IE0034224299.USD","SGXZ62798434.SGD","BK1521","LU2543165471.USD","LU0231483743.USD","LU0348766576.USD","02465","LU0823426480.USD","BK1147","LU0359201885.HKD","LU0499858438.USD","06960"],"gpt_icon":1},{"id":"2579432799","title":"啱啱 20%漲停！重磅消息 引爆！","url":"https://stock-news.laohu8.com/highlight/detail?id=2579432799","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579432799?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 14:55","pubTimestamp":1761893740,"startTime":"0","endTime":"0","summary":"今日，A股、港股创新药概念股全线爆发，三生国健、舒泰神强势录得20%涨停。消息面上，10月30日，2025年国家医保谈判在北京开启。今年国谈在延续医保目录常规调整机制的基础上，首次正式引入“商保创新药目录”机制。根据国家医保局8月28日公告，2025年基本药品目录调整有535个药品通用名通过形式审查。5年内获批上市的新通用名药品，或治疗罕见病的独家药品可申报商保创新药目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031151209a6d84f76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031151209a6d84f76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09887","BK1161","01801","BK1574","06978"],"gpt_icon":0},{"id":"2579305504","title":"身價超越宗馥莉，中國新晉女首富什麼來頭？","url":"https://stock-news.laohu8.com/highlight/detail?id=2579305504","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579305504?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 14:30","pubTimestamp":1761892207,"startTime":"0","endTime":"0","summary":"10月30日，胡润研究院发布的《2025胡润女企业家榜》显示，来自中国创新药头部企业翰森的64岁钟慧娟以1410亿元财富首次成为中国女首富，这是胡润女企业家榜二十年来的第八位新晋榜首，同时也是榜单史上第一位从事生命健康领域的女首富。截至今年上半年，公司在中国产生销售收入的创新药共有7款。钟慧娟与女儿孙远合计持有翰森制药股权比例超过60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fenghuang_stock","url":"https://finance.ifeng.com/c/8ntqSASyMqE","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.ifeng.com/c/8ntqSASyMqE","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK1583","BK1589","BK4080","BK1161","BK4231","03692","ADC","BK1191","BK1515","BK1574","09939","06978"],"gpt_icon":0},{"id":"2579933434","title":"創新藥，又現集體大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2579933434","media":"市值观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579933434?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 14:06","pubTimestamp":1761890760,"startTime":"0","endTime":"0","summary":"文丨泰罗10月31日，三生国健、舒泰神、广生堂、荣昌生物、圣诺生物、百利天恒等创新药概念股集体大涨。2024年，创新药首次出现在政府工作报告中。开年至今，创新药出海交易总金额高达455亿美元，不到半年时间已直逼去年全年的水平。2015年，中国原研创新药的研发管线只有124条，至2024年这一数据已达到704款，位居全球第一。2015年中国企业自研进入临床的FIC创新药只有9个，在全球的占比不足10%，到2024年已飙升到120个，占比已超过30%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-31/doc-infvuhux4169006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","159992","BK1161","BK1574"],"gpt_icon":0},{"id":"2580449616","title":"康諾亞-B盤中異動 股價大漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580449616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580449616?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 13:16","pubTimestamp":1761887800,"startTime":"0","endTime":"0","summary":"2025年10月31日下午盘13时16分，康诺亚-B股票出现波动，股价大幅拉升5.06%。截至发稿，该股报60.250港元/股，成交量243.3万股，换手率0.81%，振幅7.41%。康诺亚-B股票所在的生物技术行业中，整体涨幅为3.19%。其相关个股中，映恩生物-B、百奥赛图-B、药捷安康-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、华康生物医学、药捷安康-B，振幅分别为44.58%、22.86%、15.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103113164194e6d073&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103113164194e6d073&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","02162","BK1587","BK1161"],"gpt_icon":0},{"id":"2579438263","title":"醫保談判啓動，首次正式引入商保創新藥目錄機制！恒生創新藥ETF(520500)交投活躍 昨日成交額環比大增約300%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579438263","media":"新浪基金","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579438263?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 12:59","pubTimestamp":1761886740,"startTime":"0","endTime":"0","summary":"恒生创新药ETF自2025年8月以来累计吸金8.14亿元，10月以来未出现单日资金净流出，推动其基金规模与份额双双创下历史新高，分别达16.41亿元和9.74亿份，年内分别增长15.2亿元和8.52亿份。在此消息催化下，昨日创新药相关产品交投活跃，Wind数据显示目前全市场仅有的跟踪恒生创新药指数的产品——恒生创新药ETF昨日全天成交额达6.04亿元，环比增幅高达296.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-10-31/doc-infvuhuv5652533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","520500","BK1574","BK1161","159992"],"gpt_icon":0},{"id":"2579438224","title":"算力突發 「易中天」大跌！行業迎利好 熱門概念股「20cm」漲停 孖展客看好這些績優股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579438224","media":"数据宝","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579438224?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 12:31","pubTimestamp":1761885092,"startTime":"0","endTime":"0","summary":"10月以来，多只绩优创新药概念股获得融资客加仓。算力概念股调整，“易中天”光模块三巨头天孚通信、中际旭创、新易盛均跌超6%。商保创新药目录有121个药品通用名通过形式审查，其中同时申报基本医保目录和商保创新药目录的有79个。从业绩表现来看，目前发布三季报的创新药概念股中，药明康德的净利润规模最大，公司前三季度营业总收入328.57亿元，同比增长18.61%，归母净利润为120.76亿元，同比增长84.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031125133a6d815cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031125133a6d815cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU1046422090.SGD","BK1141","LU2242644610.SGD","BK1574","BK1583","LU2045819591.USD","LU0708995583.HKD","LU0320764599.SGD","LU2125910500.SGD","06978","LU0052750758.USD","02359","BK1576"],"gpt_icon":0}],"pageSize":20,"totalPage":30,"pageCount":3,"totalSize":586,"code":"91000000","status":"200"}]}}